A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2002
11/27/2002	CN1381201A Viagra beverage prepared by microalternative bioelectric field
11/26/2002	US6486210 Such as enantiomorphs of 4-fluorostyryl-2,3,4,5,6-pentafluorobenzylsulfone; antiproliferative/anticancer agents
11/26/2002	US6486207 Compositions and methods for amelioration of human female sexual dysfunction
11/26/2002	US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002	US6486177 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
11/26/2002	US6485972 WNT signalling in reproductive organs
11/26/2002	US6485960 Polycystic kidney disease 1 gene and uses thereof
11/26/2002	US6485904 DNA encoding a plasminogen activating protein
11/26/2002	US6485755 Methods of using electron active compounds for managing cancer
11/26/2002	US6485704 Azo compound for type I pototherapy
11/22/2002	WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
11/22/2002	CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092623A1 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
11/21/2002	WO2002092618A1 17 alpha-hydroxy-4-androstene-3-one and the 14, 15-methylene-derivatives thereof
11/21/2002	WO2002092596A1 Novel sulfonate substituted pyrazol pyridine dervivatives
11/21/2002	WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives
11/21/2002	WO2002092553A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002	WO2002092111A1 Use of extracts and preparations from iris plants and tectorigenin as medicaments
11/21/2002	WO2002092102A2 Treatment of conditions relating to hormone deficiencies by administration of progestins
11/21/2002	WO2002092097A1 Composition comprising phosphodiesterase inhibitors for inducing cervical ripening
11/21/2002	WO2002092090A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002	WO2002092075A2 Therapeutic delivery of carbon monoxide
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002091993A2 Estrogen receptor modulators
11/21/2002	WO2002081728A3 Quinoline inhibitors of hyak1 and hyak3 kinases
11/21/2002	WO2002079203A8 Imidazo-triazine derivatives as pde 5 inhibitors
11/21/2002	WO2002064108A3 Delivery of biologically active agents
11/21/2002	WO2002062343A3 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/21/2002	WO2002055514A3 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
11/21/2002	WO2002049649A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
11/21/2002	WO2002036171A9 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
11/21/2002	WO2002011705A3 Composition for combined use of aromatase inhibitors
11/21/2002	WO2001087350A3 Treatment of human papillomavirus (hpv)-infected cells
11/21/2002	US20020173645 Acylating a 2-aryl-6-alkoxy-benzo(b)thiophene with a p-(tertiaryaminoethoxy)benzoic acid hydrohalide salt or the corresponding benzoyl halide in presence of a boron trihalide
11/21/2002	US20020173641 Nucleotide sequences coding polypeptides for use in human therapeutics, pharmacology and diagnostics
11/21/2002	US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002	US20020173510 Nutrient mixture; fatty acid, calcium compound and vitamins
11/21/2002	US20020173499 Estrogen replacement therapy
11/21/2002	US20020173487 Cyclodextrin-drospirenone inclusion complexes
11/21/2002	US20020173485 Mixture of hyaluronic acid and polyvinylpyrrolidone
11/21/2002	US20020173464 Modulation of pericyte proliferation
11/21/2002	US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172728 Administering to the woman an effective amount of an herbal extract wherein an active ingredient in herbal extract is galanthamine for improving estrogen-deficiency related neurodegeneration and cognitive dysfunction
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172678 For regulating cellular proliferation and chemotaxis
11/21/2002	DE10123503A1 Use of Belamcanda chinensis extract, or its active ingredient, for treating sex hormone-dependent urogenital disorders and prostatic hyperplasia
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002	CA2447431A1 Inhibitors of receptor activator of nf-kb and uses thereof
11/21/2002	CA2447275A1 Therapeutic delivery of carbon monoxide
11/21/2002	CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	CA2446980A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002	CA2446849A1 Treatment of conditions relating to hormone deficiencies by administration of progestins
11/21/2002	CA2446740A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002	CA2445922A1 Estrogen receptor modulators
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/20/2002	EP1258474A2 Alkylamide compounds
11/20/2002	EP1257822A1 Her-2 binding antagonists
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257567A2 Cationic, amphipathic beta-sheet peptides and uses thereof
11/20/2002	EP1257564A1 Process of purification of hcg and recombinant hcg purified by that method
11/20/2002	EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002	EP1257554A1 Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments
11/20/2002	EP1257553A1 Pyrrolopyrimidinone derivatives, process of preparation and use
11/20/2002	EP1257547A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
11/20/2002	EP1257539A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
11/20/2002	EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002	EP1257304A1 Foam-forming wound dressing
11/20/2002	EP1257280A1 Drospirenone for hormone replacement therapy
11/20/2002	EP1257279A2 Improvement of implantation rate using ff-mas
11/20/2002	EP1257277A2 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
11/20/2002	EP1257264A1 Estrogen receptor modulators
11/20/2002	EP1257245A2 Protection of the female reproductive system from natural and artificial insults
11/20/2002	EP1165472A4 Methods for the preparation of biphenyl isoxazole sulfonamides
11/20/2002	EP1163259B1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens
11/20/2002	EP0776325B1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/20/2002	CN1380090A Kidney-supplementing gestation-promoting capsule
11/20/2002	CN1380082A Chinese medicine for curing female chronic inflammation
11/20/2002	CN1380081A Chinese medicine preparation containing curculigo rhizome and epimedium and its preparation method
11/20/2002	CN1380074A Chinese medicine thermotherapeutic liquid for external application for curing nodule in breast and its preparation method
11/20/2002	CN1380061A Transdermal preparation for curing male sexual disorder and its preparation method
11/20/2002	CN1094492C Process for preparing 'Xidinafei' medicine
11/20/2002	CN1094367C External-use medicine for curing skin disease, venereal disease and gynaopathy
11/20/2002	CN1094361C Composition comprising propolis and essential oil
11/19/2002	US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
11/19/2002	US6482426 Compositions for the treatment of male erectile dysfunction
11/19/2002	CA2272990C Heptapeptide oxytocin analogues
11/19/2002	CA2219502C Methods and formulations for modulating the human sexual response
11/19/2002	CA2092821C Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organs
11/19/2002	CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090546A1 Polypeptide serving as angiogenic marker and dna thereof
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090387A1 Reproductive cancer diagnosis and therapy
11/14/2002	WO2002090355A1 N-aroyl cyclic amines
11/14/2002	WO2002090353A1 Sulfonamides
11/14/2002	WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3

1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 557